Dr. Regina Rabinovich directs the foundationís Infectious Diseases initiative. Her portfolio includes more than $1 billion in grants for prevention, treatment, and research of malaria and other infectious diseases.
Prior to joining the foundation, Rabinovich served in various positions at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines. She participated in the Childrenís Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world, and served as liaison to the National Vaccine Program Office, focusing on vaccine safety and vaccine research. As chief of the Clinical and Regulatory Affairs Branch of the Division of Microbiology and Infectious Diseases, she managed the evaluation of candidate vaccines through a network of U.S. clinical research units. During her tenure as branch chief, the units completed large multi-center trials of pertussis and influenza vaccines, as well as a number of phase I trials of platform technologies such as an edible vaccine, and vaccines for malaria and rotavirus.
In 1999, Rabinovich became director of the PATH Malaria Vaccine Initiative, a project funded by the foundation to advance efforts to develop promising malaria vaccine candidates.
Rabinovich received her medical degree from Southern Illinois University in 1982 and her Master of Public Health degree from the University of North Carolina in Chapel Hill. She joined NIAIDís Epidemiology Training Program as a fellow in 1988.